Stereotactic radiofrequency ablation as a valid first-line treatment option for hepatocellular adenomas

Gregor Laimera Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Innsbruck, Austria

Peter Schulliana Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Innsbruck, Austria

Yannick Scharlla Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Innsbruck, Austria

Daniel Putzera Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Innsbruck, Austria

Gernot Eberlea Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Innsbruck, Austria

Georg Oberhuberb INNPATH, Institute of Pathology, Tirol Kliniken Innsbruck, Innsbruck, Austria

Reto Balea Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Innsbruck, AustriaCorrespondence[email protected]

https://orcid.org/0000-0003-0021-5792

show all

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Stereotactic radiofrequency ablation as a valid first-line treatment option for hepatocellular adenomas

Articles from other publishers (4)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Stereotactic radiofrequency ablation as a valid first-line treatment option for hepatocellular adenomas

Citations (1)

Articles from other publishers (4)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date